Work

Exophytic Shoulder Mass as Initial Presentation of a Neglected Melanoma

Year: 2026

Type: article

Abstract: P.B.-S. and C.G.-C. have nothing to declare. S.P. declares research grants/trials from Almirall, Pfizer, Regeneron, Sanofi, La Roche Posay, Philogen, ISDIN, International School of Derma, and consulting fees from Sanofi, Regeneron, ISDIN, L'Oreal, La Roche Posay, International School of Derma, and speaker fees from Sanofi, Sun pharma, Cantabria, Eucerin, ISDIN, L'Oreal, La Roche Posay, Almirall, Avene, Pierre Fabre, and support for attending meetings and/or travel from Almirall, Cantabria, ISDIN, L'Oreal. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Source: International Journal of Dermatology

DOI: 10.1111/ijd.70369

Authors: Pablo Balado‐Simó, Claudia Guilarte‐Cadavide, Natalia Castrejón‐de‐Anta, Susana Puig

Institutions: Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Universitat de Barcelona, Instituto de Salud Carlos III

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7131832371